IL33 and obesity disorder: It may participate in the mixed TH2 and TH17 cytokine phenotype in obesity since it promotes the TH17 cytokine production of ILC3s (69), the TH2 cytokine production of ILC2s (71), and primes ILC2s to become more responsive to IL-33 (117).